Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Emily Y Jen, Xin Wang, Meng Li, et al.
Elife
|
June 20, 2019
Silencing cryptic specialized metabolism in <i>Streptomyces</i> by the nucleoid-associated protein Lsr2
Emma J Gehrke, Xiafei Zhang, Sheila M Pimentel-Elardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation
Ashley C Woods, Kelly J Norsworthy, Moran Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2024
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist
T J Opgenorth, A L Adler, S V Calzadilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2015
FDA Approval: Blinatumomab
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy
Robert Q Le, Kamar Godder, Jingyan Wang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Emily Y Jen, Xin Wang, Meng Li, et al.
Elife
|
June 20, 2019
Silencing cryptic specialized metabolism in <i>Streptomyces</i> by the nucleoid-associated protein Lsr2
Emma J Gehrke, Xiafei Zhang, Sheila M Pimentel-Elardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation
Ashley C Woods, Kelly J Norsworthy, Moran Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2024
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist
T J Opgenorth, A L Adler, S V Calzadilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2015
FDA Approval: Blinatumomab
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy
Robert Q Le, Kamar Godder, Jingyan Wang, et al.
Page
of 5